Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA? (Q45732217)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2013

Language	Label	Description	Also known as
English	Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?	scientific article published in April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

0 references

Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA? (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

cerebral amyloid angiopathy

1 reference

based on heuristic

inferred from title

2

object named as

Reisa Sperling

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

David J Werring

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Annals of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

73

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

439-441

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Cerebral hemorrhage after passive anti-Abeta immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

A single ascending dose study of bapineuzumab in patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Brain microbleeds and Alzheimer's disease: innocent observation or key player?

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Clinical manifestations of cerebral amyloid angiopathy-related inflammation

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies

1 reference

https://api.crossref.org/works/10.1002%2FANA.23891

21 January 2018

Identifiers

10.1002/ANA.23891

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45732217&oldid=1521831112"